Spectrum assets poised for revaluation as strategic demand intensifies, while CRWD's guidance offsets near-term execution concerns.
Dynatrace's softening NN ARR and subscriber growth signal deceleration that caps multiple expansion.
CRWD: Q1 NN ARR of $256M missed buy-side expects > $275M. Q2/FY27 guide strong and commentary positive around Mythos impact, but still a high bar to meet.
Oppenheimer raised its price target to $50 from $25 after increasing its valuation for NextNav’s spectrum holdings to $1.50 per MHz-Pop from $0.80 previously.
The upcoming SpaceX IPO could create competitive bidding for scarce spectrum assets, particularly as SpaceX may ultimately need additional spectrum to support a direct-to-mobile strategy.
Recent private-market spectrum transactions have cleared well above historical auction levels, supporting higher valuation assumptions.
The analyst remains constructive on NextNav’s PNT opportunity, citing growing government and commercial interest in GPS alternatives and recent regulatory developments.
DT -8%: Q4/FY27 Guide Largely Inline; FY ARR guide In Line but weaker Q4 NN ARR # and Q1 subs hitting stock
Research through 2026-06-04 · 2026-05-13 to 2026-06-04 · 3 source reports.
| Range | Prices through |
|---|---|
| 1W | |
| 1M | |
| 3M | |
| 6M | |
| 1Y | |
| 2Y | |
| 3Y |
Research through 2026-11-03. Artifact validity does not establish factual accuracy or research freshness.